James B. Close

Study protocol for “Psilocybin in patients with fibromyalgia: brain biomarkers of action”

Julia Bornemann, James B. Close, Kirran Ahmad, Tommaso Barba et autres

Background: Chronic pain is a leading cause of disability worldwide. Fibromyalgia is a particularly debilitating form of widespread chronic pain. Fibromyalgia remains poorly understood, and treatment options are limited or moderately effective at best. Here, we present a protocol for a mechanistic …

gb, us (code pays fourni par la source)

Self-Medication for Chronic Pain Using Classic Psychedelics: A Qualitative Investigation to Inform Future Research

Julia Bornemann, James B. Close, Meg J. Spriggs, Robin Carhart‐Harris et autres

Background:Chronic Pain is among the leading causes of disability worldwide with up to 60% of patients suffering from comorbid depression. Psychedelic-assisted therapy has recently been found effective in treating a host of mental health issues including depression and has historically been found …

gb, us (code pays fourni par la source)

Co-design of Guidance for Patient and Public Involvement in Psychedelic Research

James B. Close, Julia Bornemann, Maria Piggin, Sandra Jayacodi et autres

Within the context of scientific research, patient and public involvement (PPI) is defined as research performed "with" or "by" patients and members of the public, rather than "to," "about", or "for" them. When carried out systematically and thoughtfully, PPI has the potential …

gb (code pays fourni par la source)

Psychedelics and psychological flexibility – Results of a prospective web-survey using the Acceptance and Action Questionnaire II

James B. Close, Eline C. Hajien, Rosalind Watts, Leor Roseman et autres

gb (code pays fourni par la source)